July 6, 2022 Acad, Gov/Utilities FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma Read more
June 29, 2022 Clinical Research/Diagn. Microscopy Product Launch Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care Read more
June 28, 2022 Clinical Research/Diagn. Product Launch Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics Read more
June 16, 2022 Product Launch Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options Read more
June 16, 2022 Uncategorized Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease Read more
June 15, 2022 Acad, Gov/Utilities Life Science Tools PR/Corporate Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19 Read more
June 10, 2022 Acad, Gov/Utilities Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting Read more
June 9, 2022 Acad, Gov/Utilities Clinical Research/Diagn. U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib) Read more
June 9, 2022 Uncategorized European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer Read more
June 8, 2022 Uncategorized European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma Read more
